High-Dose-Rate Brachytherapy as a Solution for Localized Recurrent Prostate Cancer after Primary Irradiation: A 10-Year Experience

Local recurrence after primary radiotherapy is still one of the issues in the management of the prostate cancer patients. High-dose-rate brachytherapy (HDR-BT) is one of the most efficient salvage approaches; however, available data are based on rather small groups of patients. This research aims to present our experience and Results from 10 years of salvage HDR-BT for prostate cancer relapse.